These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Myocardial transmembrane potentials and adrenergic receptors.
    Author: Somani P, Guse P, Toscano P, Bassett AL.
    Journal: Adv Myocardiol; 1980; 1():189-207. PubMed ID: 6248934.
    Abstract:
    The role of adrenergic amines in the genesis of cardiac arrhythmias is well known. Electrophysiological techniques of recording intracellular potentials have led to a better understanding of the cellular mechanisms by which these amines may induce arrhythmias. Stimulation of beta 1-adrenoreceptors increases automaticity, shortens action potential duration (APD), and may enhance slow action potential (AP) formation in depolarized Purkinje fibers (PF). Excitation of alpha-adrenoreceptors prolongs repolarization and plateau phase in PF. On the basis of the spectrum of antiarrhythmic activity in vivo and qualitatively different transmembrane effects on the canine PF, beta-adrenoreceptor blocking drugs can be subdivided into two distinct categories. Recent evidence with two new highly selective beta blockers, PS-6 and mepindolol, also suggests that at least two subgroups of cardiac beta 1-adrenoreceptors can be differentiated: beta 1i for inotropic and beta 1c for chrontropic actions of catecholamines. The effects of PS-6 in 5 x 10(-5) M concentration on isolated rabbit atria showed that this agent atangonized ouabain-induced arrhythmias and contracture. PS-6 (8 x 10(-6) M or more) reduced AP amplitude, phase 0 depolarization, APD, and phase 2 plateau phase in paced canine PF. These data suggest that PS-6 exerts a direct transmembrane effect on the canine PF.
    [Abstract] [Full Text] [Related] [New Search]